PAVmed/PAVM

$2.98

28.13%
-
1D1W1MYTD1YMAX

About PAVmed

PAVmed Inc. is a multi-product, commercial-stage medical technology company. The Company operates through three lines of business: Medical Devices, Diagnostics, and Digital Health. Its subsidiary includes Lucid Diagnostics Inc., which is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device for early detection of esophageal precancer to prevent esophageal cancer deaths. EsoCheck is a noninvasive swallowable balloon capsule catheter device capable of sampling surface esophageal cells. EsoGuard is a bisulfite-converted next-generation sequencing (NGS) DNA assay performed on surface esophageal cells collected with EsoCheck. Its other subsidiary, Veris Health Inc., is a digital health company focused on enhanced personalized cancer care through remote patient monitoring using implantable biologic sensors with wireless communication along with a custom suite of connected external devices.

Ticker

PAVM

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

Lishan Aklog

Employees

124

Headquarters

New york, United States
Website
pavmed.com

PAVmed Metrics

BasicAdvanced
$15.14M
Market cap
-
P/E ratio
-$10.57
EPS
0.81
Beta
-
Dividend rate

What the Analysts think about PAVmed

Analyst Ratings

Majority rating from 4 analysts.
Buy

Price Targets

Average projection from 3 analysts.
571.14% upside
High $30.00
Low $15.00
$2.98
Current price
$20.00
Average price target

PAVmed Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-2,514.28% profit margin
QuarterlyAnnual
Q3 23
QoQ growth
Revenue
$700K
600%
Net income
$-17.6M
21.38%
Profit margin
-2,514.28%
-82.66%

PAVmed Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 17.07%
QuarterlyAnnual
Q4 22
Q1 23
Q2 23
Q3 23
Q4 23
Actual
-$3.45
-$2.85
-$2.10
-$2.40
-
Expected
-$3.80
-$3.10
-$2.85
-$2.05
-$1.89
Surprise
-9.21%
-8.06%
-26.32%
17.07%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell PAVmed stock

Buy or sell PAVmed stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing